Newsfeeds - Spark Newswire

3 minute read

Synaptogenix Provides Corporate Update And Outlines Potential Business Opportunities; Remains Well-Funded With ~$37.5M In Cash As Of Year-End 2022 And A Relatively Low Cash Burn Rate

March 7, 10:05 AM

Announces encouraging secondary endpoint results from NIH-sponsored Phase 2 clinical trial of Bryostatin-1 in advanced Alzheimer's disease patients Maintains strong financial position with approximately $37.5

SNPX

5 minute read

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

December 19, 2:38 PM

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

ACLX

1 minute read

Maxim Group Downgrades Synaptogenix to Hold

By Benzinga Newsdesk

December 19, 8:54 AM

Maxim Group analyst Jason McCarthy downgrades Synaptogenix (NASDAQ:SNPX) from Buy to Hold.

SNPX

2 minute read

Tesla, Amazon, Madrigal Pharma, Pfizer, Synaptogenix: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

December 18, 8:56 PM

Major Wall Street indices had closed in the red on Friday in the wake of a continued sell-off following the hawkish stance asserted by the Federal Reserve. Friday witnessed volatile trading as a large number of o

AMZN

4 minute read

Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

December 16, 2:47 PM

Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.

ADAG

17 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

December 16, 1:39 PM

During Friday's trading, 293 companies set new 52-week lows.

ACEL

2 minute read

Movers

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

December 16, 1:31 PM

Gainers Allarity Therapeutics (NASDAQ:ALLR) stock rose 164.2% to $0.7 during Friday’s regular session. As of 12:30 EST, this…

ALLR

1 minute read

Synaptogenix Shares Nosedive After Mid-Stage Alzheimer’s Study Fails On Primary Endpoint

By Vandana Singh

December 16, 12:57 PM

Synaptogenix Inc (NASDAQ: SNPX) announced topline data from its National Institute of Health (NIH)-sponsored Phase 2 trial of Bryostatin-1 for advanced Alzheimer's disease.

SNPX

7 minute read

This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday

By Lisa Levin

August 16, 3:28 AM

Gainers Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.

AGFY

5 minute read

Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

August 15, 12:05 PM

Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New Energy effective as of August 10, 2022.

APRN